43 reports

  • 11. Market Growth Drivers
  • Germany

It has been predicted that the rate of cancer is expected to increase by about ##% by 2020, which will lead to the discovery of potential drugs to treat cancer.

  • Cholesterol
  • World
  • Forecast
  • Archer Daniels Midland Company
  • Cargill Inc.

Discovers and develops HDL therapies indicated to treat cardiovascular and metabolic diseases Develops drugs for the treatment of digestive or inflammatory diseases and cancers A research-based pharmaceutical company that undertakes the development, manufacture, and marketing of pharmaceuti

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC

Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/ Chart) Table ##: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Mala

  • Cholesterol
  • Chronic Disease
  • Europe
  • United States
  • World

Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/ Chart) Table ##: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB &

  • Cholesterol
  • Europe
  • Japan
  • United States
  • World

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company

Cancer Mortality for Selected Sites in ## Countries (1950-##).

  • Cholesterol
  • China
  • Germany
  • Japan
  • Forecast
  • SIZE OF THE MARKET

Cancer Urine Strip Miscellaneous The professional sector is made up of tests used in hospitals, physician offices and clinics.

  • Cholesterol
  • Point Of Care Testing
  • Abaxis, Inc.
  • Alere Inc.
  • PTS DIAGNOSTICS

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

In relation to cancer risk, the EAS guidelines draw on evidence from animal and cell studies to suggest a protective role of sitosterol against certain cancers, and thus to dismiss cancer risk with recommended daily intakes of functional foods containing ##-##g/ day of p

  • Cholesterol
  • Europe
  • Danone SA
  • Raisio Group
  • Unilever PLC

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

The company offers its product portfolio in the therapeutic areas of breast cancer, colorectal cancer and lung cancer.

  • Cholesterol
  • Clinical Trial
  • Infectious Disease
  • United States
  • GlobalData's company

It also develops JX##, a chemosensitizing oncolytic immunotherapy that eradicates cancer; activates chemotherapy in cancer tissue; administers as a monotherapy to patients with breast, colorectal, and pancreatic cancer; and treats melanoma and metastatic colon

  • Cholesterol
  • Pharmaceutical
  • United States
  • Company Financials
  • Regeneron Pharmaceuticals, Inc.
  • AF-122 - Drug Profile

The company' s products include proprietary molecules, natural new chemical entities, biomarkers, metabolite, and anti cancer drugs.

  • Antimalarials
  • Cholesterol
  • United States
  • Product Initiative
  • Vitae Pharmaceuticals, Inc.
  • AMGEN INC
  • DYSLIPIDEMIA - PIPELINE BY ARISAPH PHARMACEUTICALS INC, H1 2017

THE DRUG CANDIDATE IS IN PHASE II STAGE OF DEVELOPMENT FOR NON SMALL CELL LUNG CANCER (THIRD LINE THERAPY), PANCREATIC CANCER, COLORECTAL CANCER, NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA.

  • Cholesterol
  • Obesity
  • Pharmaceutical
  • Statins
  • Esperion Therapeutics, Inc.
  • Pipeline by Amgen Inc., H1 2016

It provides prescription medicines for the treatment of diabetes, hemophilia, harmone dificiency, high blood pressure, ulcers, skin ailments, cancer, allergy, and others.

  • Cholesterol
  • South Korea
  • United States
  • World
  • Product Initiative

Alvogen develops medicines for senile diseases such as cancer, high blood pressure, diabetes, stroke, heart disease, Alzheimer' s, metabolic diseases, and others.

  • Cholesterol
  • South Korea
  • United States
  • World
  • Product Initiative

The company develops tumor activated prosoft drugs for cancer.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis
  • BEXAROTENE - DRUG PROFILE

APR ##, 2013: ADDF AND BRIGHTFOCUS FOUNDATION COLLABORATE TO FUND PHASE I STUDY OF CANCER DRUG BEXAROTENE IN ALZHEIMER' S DISEASE PATIENTS The Alzheimer' s Drug Discovery Foundation (ADDF) and BrightFocus Foundation announced a funding collaboration that will support a Phase I human

  • Cardiovascular Disease
  • Cholesterol
  • United States
  • Product Initiative
  • LipimetiX Development LLC
  • APOLIPOPROTEIN A-I (APOA-I) - COMPANIES INVOLVED IN THERAPEUTICS DEVELOPMENT

The company develops tumor activated prosoft drugs for cancer.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis

Alvogen develops medicines for senile diseases such as cancer, high blood pressure, diabetes, stroke, heart disease, Alzheimers, metabolic diseases, and others.

  • Cholesterol
  • Lipid Modifying Drug
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • Pipeline by Amgen Inc., H1 2016
  • Pipeline by Merck & Co., Inc., H1 2016

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Cardiovascular Disease
  • Cholesterol
  • United States
  • World
  • Product Initiative
  • 8.2.1 U.S.
  • U.S.: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014-2021 (USD MILLION)

This demographic shift is expected to bring more attention on preventing the occurrence of diseases associated with this age group, including cancer, stroke, diabetes, and CVD.

  • Cholesterol
  • United States
  • Forecast
  • Market Size
  • OPKO Health, Inc.

It acts on the functional site of the cancer-causing protein.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Kowa Co., Ltd.

The company provides products in key therapeutic areas including internal medicine, cancer, vaccines, inflammation and immunology and rare diseases.

  • Cholesterol
  • Pharmaceutical
  • United States
  • Company
  • Gemphire Therapeutics Inc.

Cleveland Clinic' s network of facilities includes regional hospitals; regional care centers; a children' s hospital; a research labs and facilities for pathology and cancer, eye, heart and urologic care.

  • Cholesterol
  • Therapy
  • United States
  • Company
  • Esperion Therapeutics, Inc.
  • DYSLIPIDEMIA - PIPELINE BY GOLDEN BIOTECHNOLOGY CORP, H2 2017
  • DYSLIPIDEMIA - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2017

Its pipeline products are used in the treatment of stomach cancer, lung cancer, eating disorder, angina, hair loss and musculoskeletal system disorder.

  • Cholesterol
  • Chronic Disease
  • United States
  • World
  • Product Initiative

From a liver standpoint, the major concern is that NAFLD is a risk factor for cirrhosis and liver cancer.

  • Cholesterol
  • United States
  • Company
  • Product Initiative
  • Galmed Pharmaceuticals Ltd.